Forcing drug trials outside the country

Biocon joins a growing list of Indian drug companies that are now forced to shift their clinical trials to locations outside India, including the EU and the US, where costs are much higher. Uncertainty in India's regulatory regime is the root cause. It is tempting to blame the Supreme Court, which has stayed clinical trials.

Read Full Story>>